There has been a great deal of interest from Kellogg MBA students and healthcare industry professionals alike, as they recognize the current limitations of mental health treatments and the need for additional therapies to help the millions of people around the world. The conference aims to empower attendees with a well-rounded understanding of psychedelic therapies and the barriers to their adoption, such that they continue to engage with the question of how we can address issues of equity and access to mental health treatments through commercially viable solutions.

​

This year's conference theme, Psychedelic Spring: Preparing for Full Bloom, reflects that this budding industry today is at the cusp of a new era. To get there, we must first solve fundamental business challenges and establish the supporting infrastructure needed for psychedelic therapy to fully blossom. This conference is a vibrant gathering of industry pioneers who are planting those seeds and laying the groundwork for these life-saving therapies to equitably reach the patients who need it.

​